Becker’s is proud to spotlight chief pharmacy officers who ensure that the right medications reach the right patients at the right time.
They are tasked with overseeing complex supply chains, managing formularies at enormous scale, and standing as critical guardians of patient safety within their organizations.
These leaders are driving the future of pharmacy practice by championing automation and emerging technology, shaping cost-conscious strategies that balance clinical excellence with fiscal responsibility, and developing the policies that govern how their organizations approach one of healthcare’s most essential functions.
Note: This list was compiled based on nominations and editorial research. The list is not exhaustive, nor is it an endorsement of included leaders, organizations or associated healthcare providers. Leaders cannot pay for inclusion on this list. Leaders are listed in alphabetical order.
Contact Anna Falvey at afalvey@beckershealthcare.com with questions or comments.
Jon Albrecht. Vice President and Chief Pharmacy Officer at Methodist Health System (Dallas). Mr. Albrecht has served as vice president and chief pharmacy officer for Methodist since 2018, and has served as a professor of pharmacy at the University of Texas at Austin and Texas Tech University in Lubbock. He has more than 15 years of pharmacy leadership experience, having served in management positions since 1985. In his current role, Mr. Albrecht is responsible for overseeing pharmacy services for all Methodist Health hospitals, retail pharmacies and clinics.
Chad Alvarez, PharmD. System Pharmacy Director at Carilion Clinic (Roanoke, Va.). Dr. Alvarez leads all of Carilion Clinic’s inpatient and outpatient pharmacy services, spanning hospital, retail, ambulatory, specialty and mail-order operations, and is the first leader at the organization to unify its outpatient and inpatient pharmacy departments. He implemented the region’s first specialty pharmacy operation and Southwestern Virginia’s only 24/7 retail pharmacy, deployed an EHR for pharmacy and developed Carilion’s first pharmacist-led tobacco cessation program. Dr. Alvarez led Carilion’s Covid-19 vaccine task force, overseeing distribution of the first vaccines to the system’s hospitals and the vaccination of tens of thousands of people across southwest Virginia. He has expanded ambulatory pharmacy services, established a systemwide diversion prevention program and built an accredited community pharmacy residency program, which he directs. He also added Omnicell dispensing cabinets across facilities, implemented anesthesia workstations in procedural areas and introduced the first automated prescription dispensing systems in the outpatient pharmacies. A practicing pharmacist who joined Carilion in 2006, Dr. Alvarez is president-elect of the Virginia Pharmacy Association and will serve as its president in 2027.
Lindsey Amerine, PharmD. Chief Pharmacy Officer of Cleveland Clinic. Dr. Amerine is the chief pharmacy officer for Cleveland Clinic, having assumed the role in February 2024. Dr. Amerne comes to the system from Chapel Hill, N.C.-based UNC Health, where she most recently served as interim CPO and system executive of pharmacy. In her role at Cleveland Clinic, she leads a team of pharmacy professionals. Her biggest undertaking has been enhancing automation and technology in the pharmaceutical branch. Dr. Amerine is a prolific publisher, with peer-reviewed articles across multiple journals. She presents both in the U.S. and internationally on pharmacy practice topics with the aim of improving the industry’s standard of care. Dr. Amerine has received recognition by the American Society of Health-System Pharmacists in the form of “Best Practice”, “Excellence in Medication Safety”, and “Association of Community Cancer Centers Innovator” awards.
Eric Arlia. Vice President of Pharmacy Services at Hartford (Conn.) HealthCare. Mr. Arlia is the system-level leader responsible for the strategic direction, operations and quality of pharmacy services across Hartford HealthCare, including inpatient, outpatient, specialty and retail pharmacy. A pharmacy leader at the system for more than 20 years, he previously led pharmacy operations at Backus Hospital in Norwich, Conn., the East Region and the flagship Hartford Hospital. He then designed and launched Hartford HealthCare’s systemwide pharmacy leadership structure in 2018. Under his leadership, the system established a standardized pharmacy operating model and built a comprehensive ambulatory pharmacy network in which 35 ambulatory care pharmacists now provide counseling and medication management across more than 60 clinics. During this period, specialty pharmacy revenue increased 1,300%, and the program operates as a dual-accredited specialty pharmacy. Mr. Arlia implemented smart infusion pumps with dose error reduction software across a single platform systemwide, reaching greater than 95% utilization in 2025, and guided the adoption of a unified medication dispensing and sterile compounding platform. Hartford HealthCare added two inpatient pharmacies, one retail pharmacy and three infusion pharmacies over the past several years, and the system received the American Hospital Association “Quest for Quality Prize” in 2025.
Elias “Eli” Ayoub, PharmD. Vice President of Specialty Pharmacy for LCMC Health (New Orleans). Dr. Ayoub is building LCMC Health’s specialty pharmacy services from the ground up, including a major new site at Children’s Hospital New Orleans. A results-driven leader, he has launched specialty pharmacy programs in Michigan, completed dual accreditations in under a year and designed a home infusion pharmacy from scratch. His experience spans regulatory compliance, informatics implementation and high-volume operations, including managing 27 retail locations. At a federally qualified health center in Boston, he led Epic “Willow Ambulatory” and automatic dispensing cabinet installations to modernize systems. Dr. Ayoub also serves as an Accreditation Commission for Health Care consultant, leveraging deep expertise in specialty standards and durable medical equipment.
Krist Azizian, PharmD. Chief Pharmacy Officer for Keck Medicine of USC (Los Angeles). In June 2023, Dr. Azizian became Keck Medicine of USC’s chief pharmacy officer, a role that entails the management of systemwide pharmacy operations. He also serves as chief pharmacy officer for Keck Medical Center of USC and executive director of health systems for the USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences. Throughout his tenure at Keck Medicine, he has launched pharmacy quality initiatives and grown pharmacy services across the system, with a particular focus on the expansion of oncology services. Before coming to Keck Medicine, Dr. Azizian was director of pharmacy services at Providence Tarzana (Calif.) Medical Center.
Jennifer Bair, PharmD. Vice President of Pharmacy Services and Chief Pharmacy Officer at Prisma Health (Greenville, S.C.). Since 2022, Dr. Bair has served as Prisma Health’s vice president of pharmacy services and chief pharmacy officer. She is charged with strategic oversight for systemwide pharmacy operations, with the ultimate goal of coordinating and streamlining pharmacy services across its facilities. Dr. Bair is also helping to grow the system’s ambulatory services in order to enhance patient outcomes.
Randy Ball. Former Vice President of Pharmacy and System Pharmacy Officer at Texas Health Resources (Arlington). Mr. Ball served Texas Health Resources as vice president of pharmacy and system pharmacy officer. He oversaw all pharmacy initiatives and played a key role in the distribution of vaccines, including the Covid-19 vaccine. He also supported the Texas Tech University Health Sciences Center School of Pharmacy by offering administrative management rotation opportunities to the pharmacy students. He retired from the role in late 2025.
Bob Beacher. Chief of Shared Clinical Services at Fairview Health Services (Minneapolis). Mr. Beacher leads one of the nation’s most expansive and innovative pharmacy enterprises, overseeing 26 retail pharmacies, home infusion and specialty services at Fairview Health. Under his leadership, Fairview’s home Infusion program became the first to integrate with Epic, streamlining care delivery and access. Initiatives that he has spearheaded, like “Fairview Link” and custom health coaching, have revolutionized digital patient engagement in specialty care. In 2024, Mr. Beacher launched Fairview Pharmacy Solutions, a business arm supporting other systems in pharmacy strategy and infrastructure. He also doubled participation in the medication therapy management program, now serving over 25,000 patients across 20 disease states.
Chuck Beams. Chief Pharmacy Officer at East Alabama Health (Opelika). Mr. Beams oversees East Alabama Health’s inpatient and outpatient pharmacies, laboratory operations, and rehabilitation and clinical nutrition services. He is responsible for regulatory excellence, clinical collaboration and systemwide optimization, and has aligned pharmacy operations with strategic goals. He has united the pharmacy and laboratory departments under a shared vision for quality care. In 2020, Mr. Beams served as statewide president of the Alabama Society of Health-System Pharmacists, representing more than 1,100 pharmacists and championing professional development and advocacy. He is known for mentoring emerging pharmacy leaders and fostering a culture of continuous improvement across the health system. Mr. Beams also serves as a city council member for the City of Opelika. In 2025, East Alabama Medical Center earned the antimicrobial stewardship center of excellence designation from the Infectious Diseases Society of America.
Brooke Beavers Bernhardt, PharmD. Chief Pharmacy Officer at St. Jude Children’s Research Hospital (Memphis, Tenn.). Dr. Bernhardt leads all St. Jude Children’s Research Hospital pharmacy services across inpatient, outpatient, investigational and specialty operations. Her work carries a strategic focus on advancing the pharmacy profession and improving patient care through innovation. She also serves as director of the division of pharmacy services within the department of pharmacy and pharmaceutical sciences. Dr. Bernhardt is on the faculty of the St. Jude Graduate School of Biomedical Sciences. Under her leadership, the hospital is on track to become the first U.S. institution to introduce semi-autonomous and 3D pharmaceutical compounding for direct patient care. Before joining St. Jude, she was an assistant professor in pediatric oncology and hematology at Baylor College of Medicine, and was director of pharmacy for “Global HOPE” at Texas Children’s Hospital in Houston.
Mike Brownlee, PharmD. Chief Pharmacy Officer at University of Iowa Health Care (Iowa City). Dr. Brownlee is chief pharmacy officer at University of Iowa Health Care and chief administrative officer for the health system’s university campus, with responsibility for pharmacy, pathology, radiology, supply chain, materials management, employee health, and food and nutrition operations. His work impacts 2,600 hospital-based employees, $8 billion in annual gross patient revenue and $1.4 billion in operating expenses. He served as clinical ancillary services lead for the system’s $525.6 million North Liberty (Iowa) campus, which opened in April 2025, and oversaw the opening of a new 50,000-square-foot centralized pharmacy fill location supporting the statewide clinical enterprise. Dr. Brownlee was executive sponsor for the $280 million acquisition and integration of Mission Cancer + Blood, an 18-physician oncology practice operating in 22 Central Iowa locations. Additionally, he served as clinical ancillary services lead for the January 2024 bankruptcy acquisition of Mercy Hospital Iowa City. He led his team in growing ambulatory pharmacy net income from $3.6 million to $190 million through the targeted expansion of ambulatory care and contract pharmacy programs. He co-led pump integration between BD CareFusion Alaris pumps and Epic, making UI Health Care the first site in the world to go live with the technology, and directed Iowa’s first American Society of Health-System Pharmacists-accredited pharmacy technician training program. He also serves as associate dean for clinical education at the University of Iowa College of Pharmacy and has been an American Society of Health-System Pharmacists fellow since 1997.
Ann Byre, PharmD. Vice President and Chief Pharmacy and Laboratory Officer at Allina Health (Minneapolis). Dr. Byre leads pharmacy and laboratory strategies and services across the greater Minneapolis-St. Paul area, where Allina Health’s pharmacy services have transformed into a fully integrated enterprise. Under her leadership, pharmacy’s role has grown to include a direct reporting relationship to Allina’s COO and oversight of the system’s laboratory services. Dr. Byre helped establish a profitable retail pharmacy division and an internal, dually accredited specialty pharmacy in 2017 that has achieved a 6,000% increase in monthly specialty revenues. She led the design of a nationally recognized drug diversion prevention program and implemented a biosimilar conversion program that saved $3 million in drug costs and $3 million in total cost of care. When she joined Allina as director of its retail pharmacies in 2009, the business was struggling financially, and her leadership is credited with keeping the system in retail pharmacy and turning it into a success. Dr. Byre is a past president of the Minnesota Pharmacists Association and a member of Vizient’s pharmacy executive council, and she was named a 2025 “Notable Woman in STEM” by Twin Cities Business.
Madeline Camejo, PharmD. Chief Pharmacy Officer and Vice President of Pharmacy Services for Baptist Health South Florida (Coral Gables). Since 2018, Dr. Camejo has revolutionized pharmacy services at Baptist Health South Florida, expanding ambulatory programs, enhancing acute care services, and leading Covid-19 pharmaceutical planning and vaccination efforts. She has built a comprehensive retail and specialty pharmacy infrastructure, strengthened the 340B program and planned a state-of-the-art corporate pharmacy hub. Dr. Camejo is also known for mentoring students and residents in administrative rotations. Her blend of clinical acumen and operational foresight has earned her the title of “Top Chief Pharmacy Officer of the Year” by the International Association of Top Professionals for 2025. With over 25 years of career experience, she brings expertise in informatics, business and healthcare finance.
Kristin Cannon. Chief Pharmacy Officer at SSM Health (St. Louis). Ms. Cannon is responsible for system pharmacy operational, clinical and financial performance at SSM Health, overseeing 1,200 team members, 24 hospitals, 24 community pharmacies, and specialty, long-term care, home infusion, 503B, ambulatory and population health pharmacy operations. Her team also supports the employee health plan serving SSM Health’s 40,000 employees. A healthcare executive with more than 25 years of experience across integrated delivery systems, she led SSM Health’s transformational pharmacy population health work, integrating regional ambulatory, community and pharmacy access teams into a single population health model. Ms. Cannon manages the system’s strategic pharmacy relationships with Navitus, its pharmacy benefit management company, and Civica, the public health utility SSM Health co-founded. She is part of Vizient’s pharmacy executive council and is past chair of the Pharmacy Society of Wisconsin Health System Advisory Board. Earlier at SSM Health, she served as vice president of system pharmacy population health and vice president of pharmacy operations for its Wisconsin Region. She is recognized for fostering a high-performance culture, as well as optimizing complex, matrixed organizations through systems-thinking, cross-functional collaboration and innovation.
Will Carroll, PharmD. Vice President and Chief Pharmacy Officer at Sutter Health (Sacramento, Calif.). Dr. Carroll serves as vice president and chief pharmacy officer at Sutter Health, a role he assumed in November 2025. He leads pharmacy operations across the integrated system, with responsibility spanning inpatient, outpatient, ambulatory and specialty pharmacy services. His focus is on creating a seamless, integrated experience for patients on complex medication therapies and improving quality through a system service-lines approach. Dr. Carroll joined Sutter after three years at Hackensack Meridian Health, based in Edison, N.J., where he served as vice president of network pharmacy and chief pharmacy officer. His credentials include fellowship in the American College of Healthcare Executives, reflecting expertise in health system administration alongside his clinical pharmacy training. He is a featured speaker on chief pharmacy officer leadership, and his experience leading pharmacy enterprises at two large multihospital systems underpins his approach to integrating pharmacy into coordinated, systemwide patient care.
Ruth Cassidy, PharmD. Vice President and Chief Pharmacy Officer at Montefiore Einstein (Bronx, N.Y.). Dr. Cassidy leads the strategic vision, operations and clinical integration of pharmacy services at Montefiore Einstein, overseeing inpatient and outpatient pharmacy functions with a strong emphasis on advancing ambulatory care and specialty pharmacy as drivers of future growth. She directs systemwide operations alongside site leadership and pharmacy directors, standardizing policies, procedures and workflows across hospitals, clinics and outpatient settings while expanding access by developing and scaling on-site pharmacies under a unified pharmacy identity. Dr. Cassidy redesigned the pharmacy organizational structure, establishing systemwide functions including a dedicated pharmacy IT division, a pharmacy finance arm and a medication safety and compliance function. Under her leadership, Montefiore’s 17,000-square-foot specialty pharmacy supports operations including recently launched daytime and evening delivery of medications to patients’ homes and workplaces across the tristate area. She has expanded “meds-to-beds” programs so patients are discharged with medications in hand, enhanced adherence efforts using teach-back techniques and introduced simplified packaging for patients with complex regimens. Dr. Cassidy also implemented collaborative drug therapy management and 24/7 pharmacist availability and has embedded pharmacists into new care settings, including the emergency department. She serves a five-year term as one of nine members of the New York State Board of Pharmacy.
Betty Chan, PharmD. Senior Executive Director of Pharmacy Services at Roswell Park Comprehensive Cancer Center (Buffalo, N.Y.). Dr. Chan oversees safety, quality and adherence to standards and regulations across pharmacy operations for Roswell Park, which was founded in 1898. Since joining Roswell Park in 2024, she has deepened her clinical focus on immunotherapy, cell and gene therapy, and specialty pharmacy services, with special interest in developing strategies that support oncology site-of-care transformation, options for subcutaneous delivery of pharmaceuticals, and the impact of community delivery of bispecific T-cell engager therapy, an emerging immunotherapy approach that directs T cells to target cancer cells. In her prior roles, Dr. Chan spent nearly 20 years on the faculty at the University of Southern California School of Pharmacy, developing curriculum and leading the residency training program. During her time with the Harris Health System in Houston, she was the founding residency program director for postgraduate year two oncology and was project lead in ambulatory quality improvement. She lectures internationally, shares insights on prominent expert panels and presents work at major meetings.
Kavish Choudhary, PharmD. Chief Pharmacy Officer at University of Utah Health (Salt Lake City). Dr. Choudhary provides strategic and operational oversight for all pharmacy services across University of Utah Health, a fully integrated academic system spanning five hospitals and 11 community health centers. His portfolio includes 17 retail pharmacies, four infusion pharmacies, specialty pharmacy services and a nationally recognized drug information service, all aligned with organizational priorities for quality, patient safety, access and financial stewardship. He also serves as associate dean of pharmacy practice at the University of Utah College of Pharmacy, where he helps shape the pharmacy workforce. Before his current role, Dr. Choudhary helped develop ambulatory pharmacy services at Oregon Health & Science University in Portland, opening multiple ambulatory care centers, acquiring community-based oncology practices and overseeing infusion services. He is active in state and national professional organizations, where he has championed legislation to expand the roles of pharmacy technicians and improve access to affordable medications. Earlier at University of Utah Health, he served as senior director of inpatient and infusion services and director of pharmacy support and infusion services.
Kelley Curtis, PharmD. Vice President and Chief Pharmacy Officer at St. Luke’s Health System (Boise, Idaho). Dr. Curtis has been with St. Luke’s since 2017, joining as chief pharmacy officer. Previously, she served as vice president of the population health pharmacy program at Mosaic Life Care in St. Joseph, Mo. She specializes in driving and supporting continual growth, reducing costs and delivering safe, patient-oriented pharmaceutical care. She has experience managing budgets of over $300 million. She has also led St. Luke’s in lobbying for healthcare legislation, implementing post-merger pharmacy EHR and upgrading pharmacy technologies, all while maintaining high levels of service and regulatory compliance.
Charles Daniels, PhD. Chief Pharmacy Officer at UC San Diego Health. Dr. Daniels is chief pharmacy officer for UC San Diego Health, where he manages all pharmacy services across the system. He is responsible for the oversight of inpatient, clinic, ambulatory, specialty medication, and home and infusion IV services. He is deeply involved in the creation of pharmacy transitions of care programs. He is also the associate dean of professional practice at the UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences. He assumed both roles in 2004 after serving as chief of pharmacy for Bethesda, Md.-based NIH Clinical Center for nine years. He is interested in pharmacoeconomic benchmarking’s impact on quality improvement and cost reduction, as well as technology’s influence on safety in the medication process.
Nilesh Desai. Chief Pharmacy Officer at University of Miami Health System. Mr. Desai serves as chief pharmacy officer of the University of Miami Health System, an appointment announced in April 2026. In the role, he oversees the strategy, integration and delivery of pharmacy services across UHealth. He is also responsible for financial performance, revenue optimization and expense management for the pharmacy enterprise. UHealth is the University of Miami’s academic health system and the only university-based system in South Florida. Mr. Desai joins the university-based system from Louisville, Ky.-based Baptist Health, where he served as chief pharmacy officer. There, he oversaw pharmacy services across eight hospitals, as well as infusion, specialty and community pharmacy operations.
Danielle DiBari. Senior Vice President of Business Operations, Chief Pharmacy Officer and Chief Procurement Officer at NYC Health + Hospitals (New York City). Ms. DiBari unifies and coordinates the business operations, pharmacy and supply chain pillars of NYC Health + Hospitals, reporting to the CEO to identify and drive efficiency across the system. She is the only executive nationally to hold these three roles within a single health system. Her leadership has generated hundreds of millions of dollars through strategic negotiations and streamlined operations, and her teams created hundreds of millions in new revenue through the outpatient pharmacy while expanding access to care. Ms. DiBari is guiding the implementation of clinically advanced health care technologies in support of integrated patient care. Those financial gains allow the organization to reinvest in New York’s most underserved communities. Her work at the intersection of operational excellence, innovation and fiscal responsibility are establishing a model for other systems to follow.
Jordan Dow, PharmD. Vice President and Chief Pharmacy Officer at Froedtert Health (Milwaukee). Dr. Dow became vice president and chief pharmacy officer at Froedtert in July 2022. He accepted the role after spending six years as regional pharmacy director for Mayo Clinic in Eau Claire (Wis.), where he oversaw five community hospitals. His current position marks a return to Froedtert, as his first post-graduation leadership position was clinical pharmacy manager at Froedtert Hospital. He went on to serve as manager of medication utilization and then director of the center for medication utilization and finance at Froedtert Health before assuming his role at Mayo Clinic. Dr. Dow is a member of the American Society of Health System Pharmacists.
Casey Dugan. Vice President of Pharmacy Services at Children’s Hospital Colorado (Aurora, Colo.). Mr. Dugan leads pharmacy services across a pediatric system spanning four hospitals and 12 specialty clinic and urgent care locations, with accountability for approximately $175 million in annual pharmaceutical spend and $217 million in controllable pharmacy expense. He leads a team of more than 350 pharmacists, technicians and leaders across inpatient, ambulatory, specialty and outpatient services, and oversees investigational drug services, medication safety, prior authorization infrastructure, procurement and 340B program optimization. Over the past five years, Mr. Dugan delivered $5 million to $7 million in annual cost savings through group purchasing organization optimization, contract renegotiations, therapeutic interchange, formulary management and revenue cycle work. He also implemented 340B strategies that increased annual program value by more than $3 million. His clinical and operational leadership contributed to a more than 40% reduction in adverse drug events over three years. He also led an enterprise pharmacy organizational redesign, all while supporting the opening of pharmacies at three of the system’s hospital campuses. Mr. Dugan also serves on national advisory boards and committees, including American Society of Health-System Pharmacists’ next-gen therapeutics steering committee and the Children’s Hospital Association high-cost therapy advisory group.
Carrie Dunford, PharmD. Chief Pharmacy Officer and Chief Clinical Shared Services Officer at Intermountain Health (Salt Lake City). Dr. Dunford has served Intermountain Health since April 1999, when she began working as a clinical pharmacist. Since then, she has held various pharmacy leadership positions at the system, becoming chief pharmacy officer in November 2021 and assuming the additional role of vice president of clinical services in May 2023. One of her main priorities is providing patients with high-quality care for affordable prices.
Patrice Dupart, PharmD. Vice President of Pharmacy and Apothecary-in-Chief at New York-Presbyterian (New York City). Dr. Dupart has demonstrated excellence in pharmaceutical care at New-York Presbyterian since 2018. She leads over 1,000 pharmaceutical employees across the system’s hospitals and ambulatory clinics in pursuit of the highest level of patient safety and care. In her role as vice president of pharmacy and apothecary-in-chief, Dr. Dupart strives to meet the system’s goals by advancing innovative and patient-centered clinical care, servicing the needs of the community, educating the next generation of healthcare professionals and developing groundbreaking research.
Greg Eilinger, PharmD. Director of Pharmacy for Bergen New Bridge Medical Center (Paramus, N.J.). Dr. Eilinger manages pharmacy operations for the largest hospital in New Jersey and the state’s biggest nursing home, ensuring continuity of care across inpatient, outpatient and long-term care settings. He modernized the outpatient pharmacy with customer-friendly renovations and introduced robotic automation, reducing prescription fill times significantly. Dr. Eilinger supports key programs like medication-assisted treatment for substance use disorders and manages the 340B and charity care programs at the safety-net facility. He also serves on quality and clinical research networks, including the NJ Health Care Quality Institute and HIV Prevention Trials Network.
Michael Evans. Vice President of Enterprise Pharmacy and Chief Pharmacy Officer at Geisinger (Danville, Pa.). Mr. Evans leads strategy and operations for Geisinger’s enterprise pharmacy service, which generates more than $1.6 billion in annual operating revenue. He oversees 1,600 employees across 19 retail and mail‑order pharmacies, four specialty pharmacies, telepharmacy programs and infusion pharmacy services. Additionally, he leads formulary management, pharmacy informatics, pharmacy operations for Geisinger Health Plan and managed care, pharmacy benefit management, quality programs and the medication-use system across Geisinger’s integrated delivery network. Mr. Evans is also responsible for pharmacy planning and strategy, pharmacy fellowship and residency programs and the Center for Pharmacy Innovation and Outcomes. Under his leadership, Geisinger has advanced a collaborative pharmacy practice model for acute and chronic disease management, restructured system pharmacy entities for more patient-centric care, improved affordability for patients through provider-system partnerships and achieved operational efficiencies that led to system cost savings.
Steve Fijalka, PharmD. Chief Pharmacy Officer for UW Medicine (Seattle). Dr. Fijalka, UW Medicine’s chief pharmacy officer, is an expert in health system pharmacy, medication safety, and pharmacy practice and research. He is deeply involved in the system’s distribution of medication and vaccines, most notably heading the rollout of the Covid-19 vaccine during the pandemic. Along with leading the system’s pharmacy services, he is the associate dean of the UW School of Pharmacy and an affiliate associate professor in the department of pharmacy.
Russ Funk, PharmD. CEO of Pharmacy and Home Based Services at Banner Health (Phoenix). As executive over Banner Health’s pharmacy services since 2018, Dr. Funk leads more than 2,200 employees across the six states Banner Health serves. He oversees both the pharmacies and home-based services for Banner Health’s 33 hospitals, 15 retail pharmacies, 4 specialty pharmacies, home delivery pharmacy, home infusion pharmacy, home medical equipment, home health, hospice, ambulatory pharmacy and managed pharmacy services. With extensive healthcare leadership experience in the field, he focuses on innovation to improve patient and caregiver quality of life. In 2025, for example, Banner Pharmacy Services opened its first ambulatory infusion services to expand services in the community. In 2026, he is focused on both value-based care and expanding home medical equipment. Dr. Funk is highly experienced in leading operations, sales, marketing and business development activities and teams. He has been instrumental in increasing revenue growth, operational efficiency and market share. Since he assumed leadership, Banner Pharmacy Services has bettered its discharge prescription script capture rate from 18% to 76% and grew revenue by 320%. He is also well known for identifying opportunities, developing and implementing strategies, and creating new products.
Amy Gallagher, PharmD. Vice President of Operations at Children’s Hospital of Philadelphia. Dr. Gallagher is a nationally recognized pharmacy executive with more than 25 years of leadership shaping pediatric pharmacy practice. She provides enterprise oversight of an integrated, systemwide pharmacy program encompassing clinical practice, operations, technology, contracting and financial performance across the continuum of pediatric care. She has led the evolution of CHOP’s pharmacy enterprise to support inpatient, ambulatory, specialty, retail and home infusion services, including the successful launch of CHOP’s specialty pharmacy, retail pharmacy and centralized prior authorization program, driving sustained growth while improving access and the patient and employee experience. Dr. Gallagher has facilitated cross departmental care model redesigns that strengthen collaboration and improve care coordination. She has also guided pharmacy readiness for advanced and highly specialized pediatric therapies, continuing to build infrastructure that enables emerging biologics and precision medicine to reach patients faster. Dr. Gallagher serves as chair of the Children’s Hospital Association pharmacy executive steering committee, fostering collaboration among pharmacy executives from children’s hospitals nationwide to shape strategy, policy and best practices. She also holds numerous leadership roles and member board seats focused on medication safety, pediatric access, pharmacy innovation and advocacy.
Shabnam Gaskari, PharmD. Vice President of Clinical Services and Chief Pharmacy Officer at Stanford Medicine Children’s Health (Palo Alto, Calif.). Dr. Gaskari leads an integrated clinical enterprise spanning pharmacy, clinical nutrition, laboratory services, and cell and gene therapy programs across inpatient, outpatient, specialty, infusion and home-based care. She led the development of an AI-driven total parenteral nutrition model that advanced precision dosing and improved neonatal outcomes, work published in Nature Medicine and recognized with a “Top 10 Clinical Research Achievement Award” from the Clinical Research Forum. Under her leadership, the organization earned the Utilization Review Accreditation Commission “Pioneer Award for Excellence” in patient management for two consecutive years, and her work in cell and gene therapy earned the Vizient “Innovation Visionary Award.” Dr. Gaskari was one of only seven chief pharmacy officers invited to the White House as part of the Cancer Moonshot initiative to address drug shortages, contributing to a first-of-its-kind drug resiliency and transparency pilot. As chair of the Children’s Hospital Association’s pharmacy executive steering committee, she led negotiation of a Vizient contract for 33 hospitals, delivering significant cost savings. She also launched a pharmacist-led infusion suite that expands pediatric access and generates new revenue, and she serves as a commissioner for the Health Plan of San Mateo.
Antony Gobin. Chief Pharmacy Officer and Vice President of Pharmacy at Loma Linda (Calif.) University Health. Dr. Gobin provides executive leadership and strategic oversight for pharmacy services across Loma Linda University Health, a multi-hospital academic system, with responsibility for inpatient hospitals, ambulatory infusion centers, outpatient pharmacies, specialty pharmacy services and home health pharmacy programs. He has led systemwide initiatives advancing medication safety, optimizing operations and expanding patient access, including the opening of new outpatient pharmacies and the development of specialty and ambulatory pharmacy programs. Dr. Gobin played a key leadership role in onboarding and integrating cellular and gene therapy programs, helping establish the pharmacy infrastructure required to support those complex treatments. He has invested in building pharmacy leadership across the organization, mentoring emerging leaders and expanding the number of pharmacy specialists on patient care teams. As an associate professor at the Loma Linda University School of Pharmacy, he contributes to the education and mentorship of future pharmacists. Earlier in his career, Dr. Gobin held progressive roles including clinical pharmacist, pharmacy supervisor, medication safety pharmacist and director of pharmacy.
Melissa Goff, PharmD. Vice President of Outpatient Pharmacy at Avera Health (Sioux Falls, S.D.). Dr. Goff oversees strategy for Avera Health’s outpatient pharmacy services, including specialty, long-term care, retail and home infusion pharmacy, and the 340B program, managing a $350 million expense budget and more than 250 full-time employees. She has led the growth of Avera Specialty Pharmacy since 2015, expanding and relocating operations three times in 10 years. The team now delivers 115,000 specialty prescriptions a year and serves more than 18,000 unique patients, all while maintaining a net promoter score of 83 and an average adherence score of 0.92. Under her leadership, retail pharmacy services grew from three to 11 locations and home infusion services more than tripled, now serving 50,000 patients annually. Dr. Goff’s team oversees 340B compliance for more than 30 Avera locations and has completed more than 16 HRSA audits with no confirmed findings. She also led the growth of Avera’s long term care pharmacy, which now serves more than 8,000 patients across four states, and co-led the planning of a 65,000-square-foot pharmacy integrated services center.
Tom Greenlee, PharmD. Executive Director of Pharmacy Services at University of Missouri Health Care (Columbia). Dr. Greenlee has more than 20 years of experience as a pharmacist and joined University of Missouri Health Care in 2018 as an outpatient pharmacy supervisor. In his more than five years with the health system, he has risen through the ranks to lead its pharmacy services. Under his leadership, the system’s pharmacy service line has seen increased employee engagement and consistent delivery of exceptional customer and patient service.
Danielle Griggs, PharmD. Chief Pharmacy Officer at UVA Health (Charlottesville, Va.). Dr. Griggs leads a systemwide pharmacy enterprise at UVA Health, a five-hospital system with more than 1,000 inpatient beds, 1,400 providers and more than 1.2 million outpatient visits annually. She is responsible for 24 licensed pharmacy locations, more than 600 full-time employees, an $800 million operating budget, and $2.8 billion in patient revenue spanning acute care, ambulatory, infusion, retail and specialty services. Dr. Griggs developed and implemented the department’s first strategic plan and drove a more than 40% increase in pharmacy revenue while managing the $800 million expense budget. She led a comprehensive organizational redesign for more than 600 employees and spearheaded the UVA Health Pharmacy Central Services Center, which opened in 2026 to centralize automated fulfillment, call center operations and supply management. She also expanded the ambulatory pharmacy network and doubled centralized prescription fulfillment capacity. In 2025, Dr. Griggs received the “Distinguished Alumni Award” from the University of Kentucky College of Pharmacy, and in 2024 UVA Health earned the “High-Value Pharmacy Award” from Premier.
Amy Gutierrez, PharmD. Vice President and Chief Pharmacy Officer at John Muir Health (Walnut Creek, Calif.). Dr. Gutierrez is the vice president and chief pharmacy officer for John Muir Health, overseeing pharmacy practice, strategy and policy across the health system. She leads strategies to improve medication access and quality and leverages the value of pharmacists to drive improved health outcomes. Previously, she served as the chief pharmacy officer for UCHealth in Denver and as senior vice president and chief pharmacy officer for Oakland, Calif.-based Kaiser Permanente’s national pharmacy program. She has also served as the chief pharmacy officer for the Los Angeles County Department of Health Services. She is a clinical associate professor at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences and an adjunct assistant professor of clinical pharmacy at the USC School of Pharmacy in Los Angeles and at Chapman University’s School of Pharmacy in Irvine, Calif.
Andre Harvin, PharmD, MS, MBA. Chief Pharmacy Officer at University of Maryland Medical System (Baltimore). Dr. Harvin serves as the inaugural chief pharmacy officer of the University of Maryland Medical System, having joined the system on July 21, 2025. He came from the chief pharmacy officer role at Greensboro, N.C.-based Cone Health. He brings a blend of clinical excellence, strategic vision and a commitment to innovation in pharmacy practice. His career spans leading pharmacy services at top academic medical centers, shaping strategy at a global pharmaceutical manufacturer and contributing to a Fortune 500 healthcare company. In his role, Dr. Harvin works to unify and advance pharmacy services across the system. His leadership positions UMMS to elevate its pharmacy enterprise systemwide.
Chad Hatfield, PharmD. Vice President and Chief Pharmacy Officer at UC Davis Health (Sacramento, Calif.). As vice president and chief pharmacy officer for UC Davis Health, Dr. Hatfield oversees pharmacies, acute and ambulatory clinical services, pharmacy residents and support staff. He stepped into the chief pharmacy officer role in August 2018, along with his concurrent role as assistant dean of the UCSF School of Pharmacy in San Francisco. He is board certified in pharmacotherapy and has served in formal leadership roles since 2009.
Deborah Hauser. Vice President and Chief Pharmacy Officer at Temple University Health System (Philadelphia). Ms. Hauser leads the strategic, financial and clinical direction of pharmacy services across Temple University Health System, overseeing inpatient and outpatient operations, specialty pharmacy, retail services and medication management programs that support the system’s transplant program and Fox Chase Cancer Center. Under her leadership, pharmacy operating income is set to double by fiscal year 2026, supported by advanced dashboards that track prescription capture rates by location, specialty and medication. As chain pharmacies have exited parts of North Philadelphia and the River Wards, Ms. Hauser expanded the system’s outpatient pharmacies to address the resulting pharmacy desert. She established 24-hour pharmacy services at Temple Women & Families Hospital and launched a retail pharmacy at the Episcopal Campus focused on patients with substance use disorder, offering injectable medication-assisted therapy through a walk-in model. She expanded pharmacy infrastructure at Fox Chase Cancer Center, including advanced compounding and clean rooms, and added dedicated pharmacy support to the system’s transplant program. Her team has also integrated AI into compliance workflows to audit claims and identify savings opportunities.
Matthew Jenkins. Vice President and Chief Pharmacy Officer at VCU Health (Richmond, Va.). Mr. Jenkins is responsible for multi-hospital pharmacy services anchored by an 865-bed academic medical center, including a children’s hospital, community hospitals, ambulatory clinics, long-term care facilities, outpatient infusion, and retail and specialty pharmacy services. His oversight spans clinical and operational services, 340B integrity, pharmacy informatics, regulatory compliance, investigational drug services and a workforce of more than 450 team members across more than 20 pharmacy locations. During his first two and a half years at VCU Health, specialty pharmacy has grown more than 50%, ambulatory retail pharmacy more than 30%, and home delivery services have doubled, creating critical access points for Virginia’s largest safety-net hospital. He helped establish a systemwide medication history program and expanded meds-to-beds efforts that exceeded targeted capture rates. Mr. Jenkins also led VCU Health’s acquisition of Hope Pharmacy to prevent a pharmacy desert in the region. He previously served as senior director of pharmacy services at Charlottesville, Va.-based UVA Health and is a recipient of the “Distinguished Alumni Award” from Auburn University’s Harrison School of Pharmacy.
Tim Jennings. Senior Vice President and Chief Pharmacy Officer at Sentara Health (Virginia Beach, Va.). Mr. Jennings oversees pharmacy operations across Sentara Health’s acute care division of 12 hospitals, the system’s health plan pharmacy and the ambulatory division, including specialty, retail, Program of All-Inclusive Care for the Elderly, home care IV infusion, medical group pharmacy, population health and hospital-based infusion. With the health system since 1996, he has grown the pharmacy department from four hospitals to 12 and expanded operations beyond the inpatient setting to support ambulatory pharmacy needs. He first joined Sentara as manager of clinical pharmacy programs, became director of pharmacy in 2002, vice president in 2008, and senior vice president and chief pharmacy officer in 2019. Mr. Jennings has served on Virginia’s Department of Medical Assistance Services pharmacy and therapeutics committee since 2006, including terms as member, chair and vice chair. Earlier in his career, he was a clinical pharmacist in infectious disease at a Veterans Affairs medical center.
Jess de Jesus, PharmD. President of Beth Israel Lahey Health Pharmacy and Chief Pharmacy Officer at Beth Israel Lahey Health (Cambridge, Mass.). Dr. de Jesus provides executive leadership for BILH Pharmacy across Beth Israel Lahey Health, one of the largest health systems in Massachusetts with 14 hospitals, including academic medical centers and teaching hospitals affiliated with Harvard and UMass medical schools. He directs the strategic, administrative, financial, operational, clinical and research functions of the pharmacy enterprise across the system. Under his leadership, BILH Pharmacy has seen significant growth and diversified its services, including the addition of a home infusion pharmacy. Dr. de Jesus has been instrumental in building a large central pharmacy distribution center to serve the system’s 14 hospitals, and has led work to integrate and standardize pharmacy operations, ensure regulatory compliance and expand clinical pharmacy services. He has previously served as chief pharmacy officer at UCLA Health in Los Angeles and assistant dean at the UCSF School of Pharmacy, vice president and chief pharmacy officer at Beth Israel Deaconess Medical Center in Boston, assistant vice president and chief pharmacy officer at Phoenix-based HonorHealth, and chief pharmacy officer at the University of Miami. In 2025, the Massachusetts Society of Health-System Pharmacists named BILH Pharmacy as its “Health System of the Year,” in large part due to Dr. de Jesus’ efforts.
Thomas Johnson, PharmD. Vice President of Diagnostic and Therapeutic Services at Avera Health (Sioux Falls, S.D.). Serving as Avera Health’s equivalent to a chief pharmacy officer, Dr. Johnson oversees clinical and operational hospital pharmacy services across the health system’s member hospitals, including one tertiary medical center, five regional hospitals, and 38 community and critical access hospitals across five Upper Midwest states. He also oversees laboratory and imaging services at Avera McKennan Hospital in Sioux Falls, and in total leads a team of more than 700 full-time employees and an expense budget of approximately $400 million across pharmacy, laboratory and imaging. Dr. Johnson has published more than 50 abstracts, posters and peer-reviewed articles, and has delivered more than 100 local, national and international presentations. He has served in multiple leadership roles for the American Society of Health-System Pharmacists, including president, treasurer and board member. His accomplishments include implementing a system formulary committee, creating a centralized distribution procurement process to mitigate drug shortages, and building ambulatory care clinical pharmacy services that now include 28 pharmacists at 22 sites. He also founded and now directs Avera’s PGY-2 health system pharmacy administration and leadership residency and co-led the planning of a 65,000-square-foot pharmacy integrated services center.
Trisha Jordan, PharmD. Chief Pharmacy Officer for Ohio State University Wexner Medical Center (Columbus). As chief pharmacy officer, Dr. Jordan directs all enterprise pharmacy services. Her primary goal is to utilize education, innovation and research in support of patient-centric care delivery. Dr. Jordan’s work and research are helping to shape transformative pharmacy practice models that improve safety, quality and cost in medication use. She also serves as director for the health-system pharmacy administration residency program at the medical center and assistant dean for medical center affairs at the Ohio State University College of Pharmacy.
Girish Kaimal. Vice President of Pharmacy at Parkview Health (Fort Wayne, Ind.). Mr. Kaimal holds enterprise responsibility for pharmacy strategy, operations and financial performance at Parkview Health, with a scope spanning inpatient operations, ambulatory and clinic-based pharmacy, specialty pharmacy, home and ambulatory infusion, retail pharmacy, 340B oversight and pharmacy benefits for the employee health plan. He sets direction for clinical pharmacy services, including pharmacist integration into primary care and high-acuity service lines through collaborative practice agreements. He also owns enterprise drug-cost strategy amid drug-price inflation, biosimilar conversion and GLP-1 demand. Before joining Parkview Health, he served as chief pharmacy officer at Marshfield (Wis.) Clinic Health System, where he rebuilt the pharmacy residency program from four to 10 residents and grew departmental revenues by more than 1,200% in 16 months. Mr. Kaimal also expanded collaborative practice agreements into primary care and internal medicine, and supported the development of high-acuity ambulatory services. Trained in both pharmacy and business, he frames pharmacy investments in terms used by the C-suite and works across pharmacy, finance and clinical leadership. He is also active in developing the next generation of pharmacy leaders through residency training and student engagement.
Todd Karpinski, PharmD. Chief Pharmacy Officer at WVU Medicine (Morgantown, W.Va.). Dr. Karpinski oversees $700 million in medication spend and leads 800 pharmacy staff across 25 acute care hospitals at WVU Medicine. He has standardized pharmacy IT, procurement and clinical services while launching enterprisewide initiatives in specialty pharmacy, telepharmacy and home infusion. His efforts have improved medication safety, access and cost-efficiency across one of the nation’s most expansive rural and academic health systems. Nationally, Dr. Karpinski served a term on the American Society of Health-System Pharmacists’ board of directors. He came to WVU Medicine from his role as national director of ambulatory pharmacy for The Resource Group, a component of St. Louis-based Ascension. He previously served as chief pharmacy officer and associate dean for health system practice at Milwaukee-based Froedtert and the Medical College of Wisconsin, where over a 10-year tenure he helped build an ambulatory pharmacy model including 12 retail pharmacies, a large specialty pharmacy program, mail-order services and home infusion.
Nishaminy Kasbekar, PharmD. Vice President and Chief Pharmacy Officer for Penn Medicine (Philadelphia). Dr. Kasbekar is vice president and chief pharmacy officer at Penn Medicine. In her more than 30 years at Penn Medicine, she has served in several leadership roles for the pharmacy division. In her current role, she oversees seven hospitals and leads systemwide strategy and oversight for the pharmacy enterprise. She is also past president of the American Society of Health Systems Pharmacists and is a passionate advocate for the profession, advancing pharmacy practice through all her interactions.
Claudia Koreny, PharmD. Director of Pharmacy and Pharmacy Services for TMC Health (Tucson, Ariz.). Dr. Koreny has shaped TMC Health’s pharmacy landscape for decades, beginning as a volunteer. She now oversees inpatient and outpatient operations across four hospitals and 30 clinics. She played a critical role during the Covid-19 pandemic, managing a regional vaccine clinic that administered over 180,000 doses. Dr. Koreny spearheaded pharmacy integration following TMC’s acquisition of cancer clinics, preserving access for over 25,000 patients. When a national IV shortage hit, her quick action secured inventory and kept surgeries on track. Under her leadership, TMC’s retail pharmacy doubled its prescription volume after relocation, becoming a key resource for the community.
Dave Lacknauth, PharmD. Vice President of Pharmacy Services at Broward Health (Fort Lauderdale, Fla.). Dr. Lacknauth steers pharmacy services across hospitals and clinics at Broward Health with strategic and operational precision. His restructuring of the 340B program produced $44 million in drug savings, while his specialty pharmacy initiative generated $75 million in top-line revenue. He also negotiated $22 million in automation contracts and optimized the pharmacy benefits management plan to add $10 million in annual cash flow. In tandem, Dr. Lacknauth launched initiatives to elevate care quality, including hiring board-certified pharmacists and integrating pharmacy into population health models. He also opened a new on-site pharmacy at the Children’s Diagnostic & Treatment Center, improving access for more than 10,000 children annually.
Marjorie Lazarre, PharmD. Vice President and Chief Pharmacy Officer at Yale New Haven (Conn.) Health. Dr. Lazarre is responsible for advancing strategic pharmacy objectives across Yale New Haven Health, overseeing pharmaceutical safety, quality, regulatory compliance and fiscal performance for all pharmacy business lines. She is active nationally, with appointments to the American Hospital Association’s committee on clinical leadership, the Connecticut Hospital Association 340B subcommittee, the 340B Health executive board and Vizient’s pharmacy advocacy council, which she chairs. Dr. Lazarre pursued pharmacy to help patients and families understand and advocate for their medication therapies, motivated in part by her sister’s and daughter’s diagnoses of Type 1 diabetes. She serves as a board member for the Greater Connecticut and Western Massachusetts chapter of Breakthrough T1D, and is on the organization’s international finance and investment committee. In December 2025, she was named a gubernatorial appointee to Connecticut’s advisory council on pharmaceutical procurement. Dr. Lazarre previously served as director of pharmacy at Mount Washington Pediatric Hospital in Baltimore, and as system director and associate chief pharmacy officer at Yale New Haven.
Bonnie Levin, PharmD. Vice President of Pharmacy Services at MedStar Health (Columbia, Md.). Dr. Levin leads the pharmacy enterprise across MedStar Health’s hospitals, outpatient pharmacies and ambulatory practices. Her strategic services include specialty pharmacy, revenue integrity pharmacists, 340B and telepharmacy. She has served in multiple pharmacy leadership roles during her 20 years with MedStar Health, previously as assistant vice president of pharmacy services. Dr. Levin chairs the system’s enterprise pharmacy and therapeutics committee. She has also held multiple executive positions within the American Society of Health-System Pharmacists. The organization represents more than 60,000 pharmacists nationwide.
Timothy Lise, PharmD. Vice President of Pharmacy Services at Atlantic Health (Morristown, N.J.). Dr. Lise leads system strategy, operations and clinical innovation for pharmaceutical services across Atlantic Health’s integrated delivery network, including three retail pharmacies, six medical centers, dozens of urgent care sites and hundreds of physician offices. He oversees more than 550 pharmacy team members and the system’s annual drug spend, which exceeds $400 million. Dr. Lise leads the pharmacy leadership development series, which brings more than 70 pharmacy leaders together for two retreats a year, and launched a team member engagement effort built on a shared governance model that helped drive a Press Ganey engagement score in the 90th percentile. In 2025, he partnered with the Atlantic Health Foundation to fund a pharmacist-led opioid stewardship program recognized by the Partnership for a Drug Free New Jersey. He has been instrumental in expanding specialty and ambulatory pharmacy services, improving prescription capture and aligning pharmacy operations with enterprise priorities. Through data-driven decision-making, Dr. Lise has helped optimize payer mix, enhance contribution margin per script, and identify market share opportunities across rheumatology, neurology and oncology.
Eric Locklear. Pharmacy Director for UNC Health Southeastern (Lumberton, N.C.). Mr. Locklear oversees a diverse range of pharmacy services at UNC Health Southeastern, including inpatient, outpatient, oncology and a medication assistance clinic. His leadership has enhanced services across multiple facilities, with a focus on reaching underserved populations through the pharmacy care clinic. Mr. Locklear has been pivotal in maintaining medication access and chemotherapy compounding for the region’s cancer patients. He assumed his current role of director in 2006 after serving as assistant director and clinical coordinator since 1990.
William Loeffler, PharmD. Vice President and Chief Pharmacy Officer at Kaleida Health (Buffalo, N.Y.). Dr. Loeffler first joined Kaleida Health in May 2023 as the system’s senior director of pharmacy. In August 2024, he was promoted to vice president and chief pharmacy officer. His role entails leading systemwide pharmacy services to provide patients with top-tier pharmaceutical care. He is also charged with managing the ever-growing landscape of new medication therapies. Before coming to Kaleida Health, Dr. Loeffler spent nearly nine years at Buffalo (N.Y.) General Medical Center, serving first as pharmacy manager and then as director of pharmacy.
Michael Magee. Vice President of Case Management, Utilization Review and Chief Pharmacy Officer at BayCare Health System (Clearwater, Fla.). Mr. Magee oversees pharmacy operations across BayCare Health System, West Central Florida’s largest health system with 16 hospitals and nearly 34,000 team members, leading an approximately 700-member pharmacy team. His scope extends beyond acute care pharmacy to an Food and Drug Administration-approved central compounding pharmacy, a 503B outsourcing facility, home care infusion, specialty pharmacy and population health programs. Additionally, he oversees the system’s social work and utilization review teams. With more than 40 years of clinical experience, he is the first and only individual at BayCare to hold the chief pharmacy officer title, as well as the first in Florida. One of his most significant accomplishments is creating BayCare’s pharmacy residency program, which over 25 years has expanded to 14 hospitals, making it the largest in the state. Mr. Magee is a past president of the Florida Society of Health-System Pharmacists, an associate clinical professor at the University of Florida College of Pharmacy and a 2016 recipient of the “Latiolais Leadership Award” from The Ohio State University. He has mentored individuals who have gone on to serve as hospital CEOs, academic faculty and insurance executives.
Dave Mangan, PharmD. Chief Pharmacy Officer for UMass Memorial Health (Worcester). Dr. Mangan brings a visionary and strategic mindset to UMass Memorial Health, where he directs a $400 million drug spend and leads over 500 pharmacy staff. Within his first 18 months, he launched a consolidated service center to drive cost savings and support future home infusion and delivery services, advancing patient-centered care at scale. He also expanded an ambulatory clinical service line fourfold, embedding pharmacists and advanced practice providers to manage complex drug therapies, enhance outcomes and generate revenue. Dr. Mangan earned the American Society of Health-System Pharmacists “Certified Pharmacy Executive Leader” credential in May 2024.
Brian Marden, PharmD. Vice President and Chief Pharmacy Officer at MaineHealth (Portland). Dr. Marden has served as chief pharmacy officer for MaineHealth for nearly a decade. In this role, he oversees patient care delivery and offers administrative leadership for systemwide pharmacy services. He is integral to the creation and application of policies that support medication quality and safety. He ensures regulation compliance, collaborates with the system’s ACO to manage pharmacy spend, oversees patient therapeutic drug use and more. Prior to assuming his current role, Dr. Marden was senior director of pharmacy at Maine Medical Center, the flagship of MaineHealth.
Laura K. Mark, PharmD. Vice President of Pharmacy at Allegheny Health Network (Pittsburgh). Dr. Mark provides strategic and operational leadership for pharmacy services across 10 hospitals, nine outpatient pharmacies, and 17 infusion centers. She drives safety, standardization, and regulatory excellence while advancing technology enablement across the medication-use process. Dr. Mark has led major platform standardizations, including BD devices, IV/syringe/PCA pumps and Omnicell, and executed multiple new-build and renovation projects. In 2024, she surpassed financial targets with $16.7 million in savings and revenue optimization while expanding clinical pharmacy services and governance. Her portfolio includes ambulatory growth, centralized prior authorization and refill operations, anticoagulation services, and medication policy stewardship, all aligned to 340B compliance. Dr. Mark also serves on the dean’s advisory board at Duquesne University and previously held leadership roles at several hospitals and at McKesson Med Management.
Melanie Massiah-White. Vice President and Chief Pharmacy Officer for Inova Health System (Falls Church, Va.). Ms. Massiah-White leads pharmacy operations across Inova Health System, overseeing a $250 million medication spend and a workforce of over 450 professionals. She spearheaded the implementation of an integrated pharmacy automation system, unifying disparate workflows and systems into a standardized enterprise platform across multiple care sites. By assembling a cross-functional team from pharmacy, nursing, anesthesia and informatics, she aligned systemwide medication workflows with Institute for Safe Medication Practices best practices, significantly improving safety and efficiency. Her leadership in inventory optimization and automation standardization has yielded notable cost savings and operational improvements. Beyond operations, she established robust career pathways, starting from pharmacy technician training through to pharmacist roles, promoting talent development within Inova. Notable achievements include vaccinating over 450,000 residents during the Covid-19 pandemic and a strategic response to 2025’s fluid shortages.
Scott McAuley. Vice President of Pharmacy and Lab Systems for Piedmont (Atlanta). Mr. McAuley is the strategic and operational leader for both pharmacy and lab services across the Piedmont system. He led the integration of disparate hospitals into a unified pharmacy structure, ensuring consistency, safety and efficiency across care settings. Mr. McAuley was instrumental in establishing a specialty pharmacy program and launching a pharmacy informatics and medication safety department. Beyond operations, he contributes nationally through leadership roles on the Georgia Society of Health-System Pharmacists board and Pharmacy Technician Certification Board stakeholder advisory council. His community engagement includes serving on the board of a local clinic for underserved populations.
Karen McConnell, PharmD. Chief Pharmacy Officer at University of Michigan Health (Ann Arbor). Appointed in February 2024, Dr. McConnell brings over 20 years of clinical pharmacy and leadership experience to her role as chief pharmacy officer for Michigan Medicine and as associate dean for clinical affairs at the University of Michigan College of Pharmacy. She oversees a wide range of services, from inpatient and outpatient pharmacy operations to home infusion, specialty care and clinical pharmacy services, ensuring alignment between academic and clinical priorities. Previously the chief pharmacy officer for Chicago-based CommonSpirit Health, she has led large-scale initiatives across a 24-state health system and brings a national perspective to academic medical leadership. Her research focuses on optimizing formulary decisions, improving ambulatory outcomes and advancing professional development for pharmacy students. Through her dual appointment, Dr. McConnell mentors future pharmacy leaders while promoting integrated, patient-centered care across one of the nation’s top academic health systems.
Ryan Mezinger. Senior Vice President and Chief Pharmacy Officer for MetroHealth System (Cleveland). Since joining MetroHealth in 2015, Mr. Mezinger has led the significant growth and transformation of MetroHealth’s pharmacy services. During his tenure, the department has expanded from roughly 50 employees and four pharmacies to a network of 12 patient‑facing pharmacies supported by more than 425 team members, along with a 25,000‑square‑foot centralized pharmacy service center that houses specialty pharmacy, prior authorization operations, home delivery and compliance packaging. He has also overseen initiatives that have improved patient experience and operational efficiency, including adopting Epic’s pharmacy software to integrate prescription tracking into a 360‑degree care model, introducing a “meds to beds” program to ensure patients leave the hospital with essential medications in hand, improving internal pharmacy capture rates to elevate the patient experience, and implementing AI‑driven tools to streamline the prior authorization process, thus reducing submission times and improving approval rates. Additionally, he has supported the development of MetroHealth’s upcoming 24/7/365 retail pharmacy with drive‑thru service at the Outpatient Health Center, further expanding access and convenience for patients. Appointed senior vice president and chief pharmacy officer in March 2024, Mr. Mezinger brings nearly two decades of retail pharmacy experience to his role. In 2024, he earned the “Timothy D. Moore Pharmacy Management Award” from the Ohio Society of Health‑System Pharmacy.
Dawn Moore, PharmD. Vice President and Chief Pharmacy Officer at Community Health Network (Indianapolis). Dr. Moore provides strategic, clinical, operational and financial leadership for a fully integrated pharmacy enterprise with more than 200 sites of care. Her work spans inpatient, ambulatory, specialty, retail, infusion and home care pharmacy services, including oversight of the 340B program. Under her leadership, the specialty pharmacy program achieved more than 340% growth in revenue and operating margin, and has earned dual Utilization Review Accreditation Commission and Accreditation Commission for Health Care accreditation. She led enterprise drug utilization and benchmarking strategies that reduced drug expense per adjusted admission and patient day by an average of 40% over six years, and oversaw multiple Health Resources and Services Administration 340B audits with no findings. Dr. Moore made history as the first pharmacist from Indiana elected to the board of directors of the American Society of Health-System Pharmacists and the first African American elected president of the Indiana Pharmacy Association. Her honors include the American Black Health System Pharmacists’ “Wendell T. Hill Award” and the Indiana Pharmacy Association’s “Glen Sperandio Award.” She previously served as vice president and chief pharmacy officer at Indiana University Health in Indianapolis.
Paul Morris. Corporate Director of Pharmacy Services at Emanate Health (Covina, Calif.). Mr. Morris oversees all pharmacy operations across Emanate Health’s three hospitals, ensuring safe, compliant medication management across inpatient, outpatient, surgical, emergency and specialty services. He opened and oversees the infusion pharmacy, which prepares chemotherapy, immunotherapy, biologics and related medications and coordinates closely with oncologists and infusion nurses. Mr. Morris also launched and now directs the system’s specialty pharmacy, which accelerates prior authorizations, supports adherence and offers home delivery across disease states including oncology, rheumatology, dermatology, gastroenterology, neurology, pulmonology, endocrinology and infectious diseases. He manages and optimizes the health system’s 340B drug pricing program, ensuring compliance and program integrity while maximizing savings to expand patient access. Across the three high-acuity facilities, he provides operational, clinical and strategic leadership while fostering a collaborative culture that empowers staff. He has played a large role in transforming pharmacy services into an integrated, patient-focused model that expands access and enhances clinical quality.
Lisa Mulloy. Senior Vice President and Chief Pharmacy Officer at Northwell Health (New Hyde Park, N.Y.). Ms. Mulloy oversees clinical, operational, financial, regulatory, ambulatory and supply chain pharmacy services at Northwell Health, with responsibilities encompassing inventory management, revenue cycle optimization, drug diversion surveillance and clinical decision support. Her three-decade career at Northwell spans research, oncology and pediatrics before she moved into the revenue cycle, where she mastered billing, billing regulations and coding, and she works collaboratively with Vivo Health, the system’s retail and specialty pharmacy division. She played a central role in Northwell’s transition to the Epic EHR, with her team serving as experts who approved order sets and system builds and established new protocols for medication data management. Ms. Mulloy is driving the pharmacy department toward more advanced analytics, using AI logic within Epic and exploring predictive supply chain models. She contributes to Northwell’s PGY2 administrative residency program and recently developed a certified pharmacy technician training program within the system. She has been with Northwell Health for more than 31 years, previously serving as assistant vice president of pharmacy operations and director of pharmacy operations and revenue cycle.
Shawn Myers. Vice President of Pharmacy and Ancillary Clinical Services at Encompass Health (Birmingham, Ala.). Mr. Myers became Encompass Health’s vice president of pharmacy and ancillary clinical services in 2022. His primary focus is propelling the pharmacy and respiratory therapy practices forward for the system. To do so, he works collaboratively with the home office team, as well as regional and hospital leaders. Before his promotion to his current role, he served as the organization’s national director of pharmacy operations since 2016. Mr. Myers is part of the American Society of Health-System Pharmacists and chairs the pharmacy subcommittee for the Federation of American Hospitals.
Todd Nesbit, PharmD. Chief Pharmacy Officer at The Johns Hopkins Hospital and Vice President of Pharmacy at the Johns Hopkins Health System (Baltimore). Dr. Nesbit manages the strategic planning and implementation of pharmacy services across the Johns Hopkins sites of care and oversees the establishment of facility policies, procedures and standardization systemwide. In his more than two decades with the health system, he backed the development and implementation of clinical pharmacy programs and services as well as provided oversight of services and teams across the full continuum of the pharmacy department.
Kemi Olatunji, PharmD. Vice President and Chief Pharmacy Officer for Riverside Health (Newport News, Va.). Dr. Olatunji has served as chief pharmacy officer of Riverside Health since August 2025, providing executive leadership for pharmacy services across the integrated health system. Since her appointment, the system has expanded specialty pharmacy by 46% and infusion services by 51%, advanced innovative medication access strategies, and strengthened enterprisewide pharmacy operations to support high-quality, patient-centered care. Nationally, Dr. Olatunji serves on the 340B Health pharmacy services committee, where she chaired the 340B Health rebate workgroup and briefed congressional staff on the importance of the 340B program. She is also an active contributor to the American Society of Health-System Pharmacists’ Pharmacy Accountability Initiative 2030 and the Virginia Hospital & Healthcare Association’s 340B Workgroup. A sought-after speaker on pharmacy leadership, specialty pharmacy, infusion strategy and the evolving 340B landscape, Dr. Olatunji presents regularly at national conferences and industry forums. Throughout her career, she has championed innovation, interdisciplinary collaboration, and the strategic integration of pharmacy services to improve patient outcomes while creating sustainable value for the health systems she serves. Her leadership continues to position Riverside Health at the forefront of advancing pharmacy practice and delivering high-value, patient-centered care.
Jeff Oliver. Vice President and Chief Pharmacy Officer at Orlando (Fla.) Health. Mr. Oliver leads an enterprisewide pharmacy strategy across Orlando Health, with work spanning inpatient hospitals, outpatient and retail pharmacies, infusion centers and physician practices in Florida and Alabama. In total, he oversees approximately 1,000 pharmacy team members. As the system’s inaugural chief pharmacy officer, he led the transition to a standardized reporting model under hospital COOs, improving financial performance and clinical consistency. In just over two years, Mr. Oliver more than doubled outpatient pharmacy revenue and is opening three new outpatient pharmacies in the current year, including locations at two new hospitals and the downtown Orlando Health Children’s Pavilion. He introduced AI and advanced analytics into pharmacy workflows, automating financial assistance matching and reducing prior authorization processing times, and has implemented real-time, enterprisewide drug diversion monitoring. He reimagined the system’s meds-to-beds program into “Scripts to Go,” offering bedside delivery, secure on-site kiosks and direct-to-home delivery. Mr. Oliver previously served as vice president of pharmacy at Atlas Health, and has held pharmacy leadership roles with St. Louis-based Ascension and Nashville, Tenn.-based HCA Healthcare.
Melissa Ortega, PharmD. Chief Pharmacy Officer at Mass General Brigham (Boston). With more than a decade of healthcare leadership, Ms. Ortega oversees the health system’s transformation of pharmacy services across academic medical centers, community hospitals and ambulatory practices. She leads an enterprisewide effort to standardize pharmacy practice, elevate operational efficiency, advance models of care, and embrace a unified system strategy across a pharmacy workforce of more than 1,100 employees with annual drug spending exceeding $1.5 billion. Under her leadership, Mass General Brigham Pharmacy is designing and implementing a systemwide infusion strategy and transformative ambulatory care models that improve medication access and align with population health initiatives. She is also driving a comprehensive sterile compounding licensure strategy to ensure regulatory compliance and harmonizing formularies across the enterprise. Previously she served as system vice president of ambulatory pharmacy services at Boston-based Tufts Medicine and held leadership roles including president and legislative chair of the Massachusetts Society of Health-System Pharmacists and inaugural chair of the American Society of Health-System Pharmacists Section of Community Pharmacy Practitioners. She is actively engaged in national advocacy, research and education.
Binita Patel, PharmD. Vice President of Pharmacy Services at Memorial Hermann Health System (Houston). Dr. Patel has served as vice president of pharmacy services at Memorial Hermann since 2019, joining the system from AmerisourceBergen where she served as a managing director. She also served as director of ambulatory care and retail pharmacy at Froedtert Hospital in Milwaukee. Dr. Patel specializes in healthcare management and was named a “TMC Healthcare Hero” by the Houston-based Texas Medical Center in 2021. She has also been dubbed a “Woman Who Means Business” by the Houston Business Journal.
Robert Pellechio. Senior Vice President and Chief Pharmacy Officer at RWJBarnabas Health (West Orange, N.J.). Mr. Pellechio was named senior vice president and chief pharmacy officer of RWJBarnabas in 2022. Previously, he served as vice president of Barnabas Health for 20 years. In his current role, he provides strategic leadership for the 25 divisions within the system’s pharmacy enterprise. He has more than 35 years of experience in healthcare, hospital administration, supply chain and pharmacy. Mr. Pellechio also has oversight over the system’s 340B functions as well as pharmaceutical contracting, which includes purchases of over $450 million in products and supplies. He is passionate about helping underrepresented communities gain access to affordable medications. He was honored as a recipient of the 2026 NJBIZ “ICON” award in May 2026.
Adam D. Porath, PharmD. Vice President of Pharmacy at Renown Health (Reno, Nev.). Appointed to the attorney general’s statewide opioid partnership and the American Society of Health System Pharmacists’ council on public policy, Dr. Porath drives innovation within Nevada and nationwide. Board member for the state board of pharmacy and a commissioner on the Nevada State Patient Protection Commission, he helped pass collaborative drug therapy management legislation and expand the pharmacy practice act. At Renown Health, Nevada’s only integrated academic health system, his team of board-certified pharmacists and pharmacy technicians manage medications across three outpatient retail pharmacies, specialty and mail order pharmacies, three in-patient pharmacies and ambulatory pharmacotherapy programs. Board certified in pharmacotherapy and ambulatory care, he is a certified pharmacy executive leader, fellow of American Society of Health System Pharmacists, associate professor of clinical pharmacology at University of Nevada, Reno School of Medicine, and adjunct clinical faculty for several colleges of pharmacy. Weeks after the only area 24/7 pharmacy closed, Renown Pharmacy stepped up to expand hours, allowing public and hospital patients to fill their prescriptions all hours and around the clock.
Ryan Roux, PharmD. Vice President for the Division of Pharmacy at the University of Texas MD Anderson Cancer Center (Houston). Dr. Roux oversees all pharmacy-related services for admitted patients, ambulatory infusion centers and retail pharmacy at the University of Texas MD Anderson Cancer Center, with leadership and operations responsibility for inpatient services spanning three ambulatory treatment centers, five Houston-area locations, a specialty surgery center and three retail pharmacy locations. Dr. Roux co-leads the institution’s value-based care initiatives, driving tens of millions of dollars in savings through strategic purchasing, disciplined medication management and strengthened contracting, while sustaining standards for quality, safety and patient outcomes. Under his leadership, the division of pharmacy has implemented new oncology stewardship programs across hematology and solid tumor service lines. He led the institution’s transition to a specialty pharmacy group purchasing organization and oversaw the opening of a newly renovated pharmacy supporting expanded infusion capacity at MD Anderson Cancer Center Northwest Houston Surgical & Specialty Care. As an active member of the UT Pharmacy Enterprise Collaborative, Dr. Roux helps advance alignment, shared services and best practices across University of Texas System academic medical centers, and he currently chairs Vizient’s pharmacy executive committee.
Sandra Salverson, PharmD. Chief Pharmacy Officer at OSF HealthCare (Peoria, Ill.). Dr. Salverson oversees a broad continuum of care at OSF HealthCare, including 18 hospital pharmacies across two states, one specialty pharmacy, one ePharmacy, a home infusion pharmacy and an integrated distribution center. She implemented a shared-service telepharmacy model that improved medication safety, reliability and continuity while remaining staffing-neutral, and expanded coverage to hospital-at-home care and the Medicaid Collaborative Initiative. Dr. Salverson has built and sustained a high-performing pharmacy workforce, increasing pharmacy technician retention from 66% to 85%, maintaining 93% five-year pharmacist retention and filling 95% of leadership roles internally over the past five years. Her work earned OSF HealthCare designation as a center of excellence in medication-use safety by the American Society of Health-System Pharmacists Pharmacy Practice Accreditation Commission.
Wafa Samara, PharmD. Vice President and Chief Pharmacy Officer at City of Hope (Duarte, Calif.). Dr. Samara is City of Hope vice president and chief pharmacy officer, a role she has held since June 2020. Beforehand, she was chief of pharmacy service for the National Institutes of Health. She has also served as chief of pharmacy for VA Central California Health Care System in Fresno, Calif. She is passionate about using pharmacy to address health disparities and improve diversity, equity and inclusion across the care continuum.
Matt Sapko. Chief Pharmacy Officer at Nationwide Children’s Hospital (Columbus, Ohio). Mr. Sapko directs the strategic vision for one of the nation’s largest pediatric pharmacy programs, focusing on pharmacy operations and education, staff and leadership development, medication safety, finance and strategic planning. He has spent his entire career at Nationwide Children’s, advancing from resident and clinical pharmacy specialist to chief pharmacy officer. Mr. Sapko has been a driving force behind the “Zero Hero” safety initiative and has positioned the hospital as a pioneer in gene and cell therapy, developing the operational and safety frameworks required to deliver those treatments. As director of the health-system pharmacy administration and leadership residency program, run in partnership with The Ohio State University, he develops future pharmacy executives. He also serves on the board of the Charitable Pharmacy of Central Ohio and on the Children’s Hospital Association pharmacy executive steering committee. Nationwide Children’s was ranked among the top 10 in the nation by U.S. News & World Report‘s 2025-26 list of best children’s hospitals, marking its 12th consecutive year on the honor roll.
Denise Scarpelli, PharmD. Vice President and Chief Pharmacy Officer at University of Chicago Medicine (Chicago). Dr. Scarpelli leads the pharmacy enterprise across University of Chicago Medicine, overseeing the medication-use system spanning inpatient and outpatient operations, clinical practice, financial management, regulatory compliance and patient safety. Under her leadership, the system became one of the first in the country to earn the American Society of Health-System Pharmacists certified center of excellence in medication-use safety and pharmacy practice designation in 2022 and secured re-designation in 2025, an achievement held by only nine health systems nationwide. In 2023, she oversaw the opening of a new outpatient pharmacy and central fill facility that doubled daily prescription volumes and now fills approximately 2,200 prescriptions a day, supporting access for patients in pharmacy deserts on Chicago’s South Side. She leads the system’s infusion strategy, expanding services across Illinois and Indiana, and has driven the integration of pharmacy operations, IT systems and formularies as the system has grown. Dr. Scarpelli served on the Illinois board of pharmacy for 10 years, including as chair from 2022 to 2025, and serves on the American Society of Health-System Pharmacists’ council on pharmacy management.
Keith R. Schissler, PharmD. Vice President of Pharmacy at Baptist Health (Jacksonville, Fla.). As vice president of pharmacy at Baptist Health, Dr. Schissler provides enterprise leadership and strategic direction for patient-centered pharmacy services across the full continuum of care, spanning acute, ambulatory and transitional care operations systemwide. As a member of the Baptist Health executive leadership team, he partners across clinical, operational, financial and technology domains to standardize pharmacy practice and deliver measurable improvements in patient outcomes, medication safety, access and cost-effectiveness. From 2022 to 2026, Dr. Schissler held dual roles as executive director of pharmacy for Baptist Health and vice president of operations at the 146-bed Baptist Medical Center Beaches, where he oversaw clinical and support departments including cardiopulmonary services, imaging, laboratory and rehabilitation. He recently played a key role in developing and launching specialty pharmacy services at Baptist Health, guiding teams through complex regulatory and accreditation requirements and integrating the operation into broader organizational goals. During the Covid-19 pandemic, he helped develop treatment guidelines, secured adequate stock of severely limited pharmaceuticals, supported vaccine provision and oversaw distribution of novel investigational agents. He also helped create a medication reconciliation telehealth technician program. In 2021, Dr. Schissler received the “Preceptor of the Year Award” from Florida A&M University’s Northeast Florida Pharmacy Practice Center for mentoring student pharmacists.
Bhavesh Shah. Vice President and Chief Pharmacy Officer for Boston Medical Center. Mr. Shah serves as vice president and chief pharmacy officer for Boston Medical Center, where he leads systemwide pharmacy strategy and oversight. A board-certified oncology pharmacist, he brings deep clinical and operational expertise to his role in one of New England’s largest safety-net hospitals. His robust research portfolio spans oncology and non-oncology topics, including biosimilars, Covid-19 therapies, iron deficiency anemia, inflammatory bowel disease and more. Mr. Shah has contributed to advancing digital adherence technologies in lung cancer and has explored novel strategies in treating chemotherapy-induced nausea and cancer-related anorexia and cachexia. His leadership bridges innovation with compassionate care, helping ensure vulnerable populations receive equitable access to life-saving medications.
Urshila Shah, PharmD. Senior Vice President and Chief Pharmacy Officer at WMCHealth (Valhalla, N.Y.). Dr. Shah serves as senior vice president and chief pharmacy officer at WMCHealth, the first executive to hold the role at the system. She joined WMCHealth in 2025 and leads its pharmacy enterprise across inpatient, ambulatory and specialty services. Her work focuses on driving innovation, improving access and enhancing patient care throughout the Hudson Valley. At the safety-net system, Dr. Shah is focused on transforming pharmacy into a growth engine. She built a decade-long foundation in clinical pharmacy before moving into systemwide leadership, a transition that gave her a top-down view of health care operations and shaped her approach to driving change.
Rita Shane, PharmD. Vice President and Chief Pharmacy Officer for Cedars-Sinai Health System (Los Angeles). Dr. Shane serves as vice president and chief pharmacy officer and professor of medicine at Cedars-Sinai Medical Center, and as associate dean for clinical pharmacy services at the UCSF School of Pharmacy. Her areas of focus include quality and safety, transitions of care, financial stewardship of high-cost medications and interdisciplinary collaboration to optimize patient care. Active in advocacy at the state and national levels, she has worked extensively with regulatory agencies, and her work has led to new California laws in tech-check-tech and transitions of care, including a State Board of Pharmacy requirement to ensure accurate medication lists for high-risk patients at admission and discharge, making California the only state with such requirements. Dr. Shane was invited by the Singapore Ministry of Health to serve as its 2027 Healthcare Manpower Development Expert in medication quality and safety. Her honors include the American Society of Health-System Pharmacists “Harvey A.K. Whitney Award,” the highest honor in health-system pharmacy, the Institute for Safe Medication Practices “Lifetime Achievement Award,” the 2022 Vizient “David A. Zilz Leadership Award” for her work developing the high value pharmacy enterprise initiative, and the 2023 “Milap Nahata Distinguished Lecture” at The Ohio State University College of Pharmacy. She was named a 2024 ScholarGPS “Highly Ranked Scholar,” with a lifetime ranking of No. 17 in the health system category. Dr. Shane has published more than 120 papers and delivered more than 260 presentations at the state, national and international levels.
Justin Simon, PharmD. System Director of Pharmacy at Christus Health (Irving, Texas). Mr. Simon has served as Christus Health’s system pharmacy director since 2020, originally joining the system as corporate director of pharmacy in 2019. Before that, he spent five years at Florida Hospital, which is now Altamonte Springs, Fla.-based AdventHealth, and eight years at CVS Health, where he worked as a pharmacy intern and pharmacist. Mr. Simon specializes in community and team building in the workplace. He is also trained in vaccine administration.
Deborah Simonson, PharmD. Vice President and Chief Pharmacy Officer at Ochsner Health (New Orleans). Dr. Simonson oversees pharmacy strategy and operations for Ochsner Health’s 47 hospitals and extensive outpatient network, with more than 40 years at the system. Over the past year, she scaled AI-enabled prior authorization and medication access tools across specialty, infusion and retail pharmacy services, accelerating time to therapy for tens of thousands of patients while reducing administrative burden for clinicians. These efforts nearly doubled pharmacy throughput per full-time employee and restored thousands of hours of clinician capacity. Dr. Simonson has built on earlier innovations including Ochsner’s centralized refill center, which streamlined prescription processing, and the deployment of pharmacists into inpatient and ambulatory settings to offset nursing shortages. Her leadership has strengthened workforce resilience, improved staff morale and enhanced the reliability of medication delivery across the system. Through digital transformation, workforce optimization and enterprise integration, she has positioned pharmacy as a driver of access, efficiency and patient-centered care at Ochsner.
Jenny Smith, PharmD. Vice President of Pharmacy Services at BJC HealthCare (St. Louis). Dr. Smith has played an integral role in pharmacy management at BJC since 2011, when she first became the manager of clinical services at the health system’s flagship hospital. In her role, Dr. Smith has contributed to multiple research projects and publications. She leads BJC’s pharmacy strategy and has more than 25 years of clinical experience.
Clyde Spence, PharmD. Vice President and Chief Pharmacy Officer at Hackensack Meridian Health (Edison, N.J.). Dr. Spence leads strategy and policy development for the pharmacy enterprise at Hackensack Meridian Health, having become the system’s chief pharmacy officer in February 2026. As prior network director of the acute care pharmacy division, he established a unified, networkwide pharmacy and therapeutics committee with a standard drug formulary, and then implemented a network drug diversion prevention program with an analytics platform. He leverages his pharmacy, legal and business degrees to enhance operations and ensure regulatory compliance, and has delivered more than $50 million in cost savings through program optimization, revenue cycle enhancements and improved formulary management. Dr. Spence also designed a 340B optimization strategy that improved program integrity while capturing new eligible savings. His 2025 accomplishments included rolling out a GLP-1 obesity center of excellence strategy with in-house pharmacies and co-developing an eKAM note summarizer tool for Epic to help clinicians meet CMS Part D measures. He previously held pharmacy leadership roles at Chicago-based CommonSpirit Health, Columbia, Md.-based MedStar Washington Hospital Center, Jacksonville, Fla.-based Ascension St. Vincent’s and Charleston (W.Va.) Area Medical Center.
Buck Stanford, PharmD. Vice President and Chief Pharmacy Officer at IU Health (Indianapolis). Dr. Stanford joined IU Health in 2019 as vice president and chief pharmacy officer. Previously, he served as pharmacy operations director for community based care at Salt Lake City-based Intermountain Healthcare. In his current role, he is focused on consolidating hospital- and clinic-based pharmacy operations, developing a strong team in partnership with the system’s human resources department, creating a five-year strategic plan for pharmacy operations, developing a centralized pharmacy hub for the system, creating internal pharmacy process standards and rolling out a new digital platform pharmacy services platform. He has over 25 years of experience leading various aspects of healthcare operations, as well as expertise in delivering operational and clinical initiatives to improve quality, efficiency and market share.
Brandi Strader. System Director of Pharmacy at Hospital Sisters Health System (Springfield, Ill.). Ms. Strader leads the pharmacy service line at Hospital Sisters Health System, a Catholic health care system of 13 hospitals and an integrated physician network serving communities throughout Illinois and Wisconsin. Since assuming the role in December 2023, she has implemented an organizational structure that enabled rapid deployment of standard processes across the system and represents the system at industry events and its group purchasing organization. She was instrumental in implementing IV fluid conservation measures during the IV fluid crisis, and led the acquisition and implementation of new Pyxis cabinets and IV pumps systemwide. Ms. Strader is overseeing the implementation of a new systemwide specialty pharmacy service line in Springfield and in Green Bay, Wis. to support patients with complex, chronic and rare conditions. Since joining the system in 2010 as a registered pharmacist, she advanced through roles as clinical coordinator, supervisor, manager and pharmacy director, and implemented the first emergency room pharmacy at HSHS St. John’s Hospital in Springfield. She has also focused on improving patient satisfaction, reducing medication errors and fostering a more collaborative environment.
Mark Sullivan, PharmD. Chief Pharmacy Officer at Vanderbilt Health (Nashville, Tenn.). In his role, Dr. Sullivan is responsible for Vanderbilt Health’s hospital operations, its retail, specialty and multiple contract pharmacy enterprise, and its corporate pharmacy services. Through his leadership, the health system maintains its high-performing pharmacy workforce. Dr. Sullivan has served in advancing clinical, operations and leadership roles for more than three decades.
Jack Temple, PharmD. Vice President of Pharmacy Services at UW Health (Madison, Wis.). Dr. Temple provides enterprise leadership for integrated clinical, operational, financial, regulatory, informatics and supply chain pharmacy functions across UW Health’s academic health system, including specialty pharmacy, infusion services, 340B, automation and procurement. With more than 15 years of progressive leadership at UW Health, he has advanced pharmacy practice as a strategic driver of quality, safety and system performance. A defining achievement is his use of health IT and innovative service models to transform pharmacy operations; he deploys automation, advanced analytics and informatics to improve accuracy and scalability while increasing pharmacist capacity for clinical engagement. Dr. Temple has held national leadership roles within the American Society of Health-System Pharmacists and Vizient, including chairing committees focused on medication use, informatics and pharmacy business strategy. He is recognized for building strong teams and mentoring pharmacists and leaders. Under his leadership, UW Health earned the 2025 National Association of Specialty Pharmacy “Specialty Pharmacy of the Year” recognition and an Infectious Diseases Society of America antimicrobial stewardship center of excellence designation.
Cedric Terrell, PharmD. Chief Pharmacy Officer at CommonSpirit Health (Chicago). Dr. Terrell serves as chief pharmacy officer of CommonSpirit Health, a role he assumed in fall 2025. He previously served as chief pharmacy executive at University of California Health in Oakland, where he had been chief pharmacy officer since October 2023. There, Dr. Terrell expanded specialty and retail pharmacy access, strengthened pharmacy benefit partnerships and advocated for the federal 340B program. He also led development of a systemwide pharmacy strategy to enhance alignment between inpatient and outpatient services. Dr. Terrell brings extensive experience as a pharmacy executive, having served as chief pharmacy officer at Blue Cross Blue Shield of Massachusetts and vice president of pharmacy at Novant Health, based in Winston-Salem, N.C.
Jeff Thiel, PharmD. System Vice President of Pharmacy for Endeavor Health (Evanston, Ill.). Dr. Thiel has spent over 15 years rising through the pharmacy leadership ranks at Endeavor Health, culminating in his current role overseeing systemwide pharmacy services. As the residency program director for postgraduate year two health system pharmacy administration, he actively cultivates leadership in future pharmacy professionals. His long-standing commitment to innovation helped Endeavor achieve top Epic gold stars in genomics and rank 19th nationally on Gartner’s “Healthcare Supply Chain Top 25” for 2024. Dr. Thiel was also a key player in the organization’s brand transformation from NorthShore–Edward-Elmhurst Health to Endeavor Health. Thanks to his previous leadership roles across various Endeavor hospitals, he brings deep operational fluency within diverse care environments.
Jennifer Tryon, PharmD. Chief Pharmacy Officer for Henry Ford Health System (Detroit). Dr. Tryon joined Henry Ford Health System as chief pharmacy officer in 2021, following a five-year tenure in the same role at Winston-Salem, N.C.-based Wake Forest Baptist Health. She leads the system’s inpatient, outpatient and health plan pharmacy teams. She is also responsible for the strategic direction, integration and evaluation of the integrated network’s pharmacy programs. Her role directly impacts the safety and quality of the care patients receive.
Misty Vo, PharmD. Pharmacy Director at Valleywise Health (Phoenix). Dr. Vo is responsible for pharmacy services across Arizona’s only public teaching hospital and safety-net health system, including three inpatient facilities and 11 outpatient and retail pharmacies. An accomplished leader with more than 20 years of experience, she began her career as a licensed pharmacy technician before earning her pharmacy degree and advancing through the field, specializing in medication management, regulatory compliance, patient safety and fiscal stewardship. Dr. Vo drove a significant expansion of Valleywise Health’s meds-to-beds program, improving discharge efficiency, reducing medication-related readmissions and strengthening adherence through bedside delivery and patient education. She advanced ambulatory clinical pharmacy services through grant-funded programs that embed clinical pharmacists in outpatient practices, and established a comprehensive in-house patient assistance program to reduce cost-related barriers to care. She provided executive oversight for a major pharmacy renovation and expanded the pharmacy residency program to include a behavioral health focus. Before joining Valleywise Health, Dr. Vo held pharmacy roles at Phoenix-based Banner Health from 1995 to 2018.
Joy Vreeland, PharmD. Vice President and Chief Pharmacy and Therapeutics Officer at Boston Children’s Hospital. Dr. Vreeland provides executive leadership over Boston Children’s Hospital’s department of pharmacy, which has more than 200 employees providing advanced pharmacy services around the clock. She also serves as a member of the organization’s senior management group. The department is responsible for medication therapy management, housewide order review, medication distribution, drug information, pharmacokinetic services, code response and antimicrobial stewardship. Her leadership was essential to launching an integrated specialty pharmacy program through a collaboration with Shields Health Solutions, designed to support patients with rare and complex illnesses by assisting with prior authorizations, financial assistance and other barriers to care. To support that launch, Dr. Vreeland oversaw the relocation of the hospital’s patient-facing pharmacy to a new, independent location that does not require families to navigate the hospital, accomplished without interruption to prescription services. She was also instrumental in opening a specialty pharmacy on the Longwood campus and implementing a collaborative drug therapy management pharmacist program to improve safety and speed access to high-cost therapies. Before joining Boston Children’s in 2022, she spent more than 23 years at Boston Medical Center, ultimately as associate chief pharmacy officer.
Jeffrey L. Wagner, PharmD. Vice President of Pharmacy at Texas Children’s Hospital (Houston). Dr. Wagner leads systemwide pharmacy strategy for the nation’s largest pediatric health system, overseeing a team of more than 600 across four hospitals as well as specialty, home infusion and retail pharmacy operations with more than $400 million in annual medication spend. He spearheaded the modernization of pharmacy operations through a radio frequency identification-enabled inventory management model that delivers real-time visibility into high-cost medications, reducing a 12-step manual inventory process to two steps and enabling 24/7 medication tracking and expiration monitoring. The initiative helped avoid up to $40 million annually in inventory waste and generated $14 million in annual savings on select therapies despite increased utilization, while improving charge capture. Dr. Wagner helped lead the development of a 40,000-square-foot centralized pharmacy facility in Missouri City, Texas, supporting specialty and infusion care for nearly 4,000 patients. Nationally, he serves on the Children’s Hospital Association pharmacy executive steering committee, the Epic pharmacy executive advisory board and the Vizient pharmacy business council, and is immediate past president of the Texas Society of Health-System Pharmacy. He also advises national efforts addressing pediatric drug shortages and supply chain resiliency.
Michael Wascovich, PharmD. Chief Pharmacy Officer and Vice President of Medication Management for Ascension (St. Louis). Dr. Wascovich serves as vice president of medication management and chief pharmacy officer for Ascension, one of the nation’s largest nonprofit and Catholic health systems, where he leads all aspects of pharmacy services, including business and operational strategy, medication safety and quality, supply chain performance, and internal and external partnerships. He oversees a fully integrated pharmacy model spanning acute, ambulatory and post-acute settings, including community pharmacies, specialty pharmacy, home delivery services and embedded clinical pharmacy teams. A core focus of his role is improving medication access, affordability and adherence for patients who are uninsured or underinsured, and he leads Ascension’s charitable pharmacy strategies, including its partnership with Dispensary of Hope. Through that partnership and related programs, Ascension dispenses more than 71,000 prescriptions annually and has contributed to nearly $200 million in medication access for underserved populations. Dr. Wascovich drives innovation through data and technology, using analytics to identify gaps in prescription fulfillment and deploying automation and AI-enabled tools that have improved workforce efficiency by 25% to 40%. In 2026, he was named board chair of the End Drug Shortages Alliance, leading efforts to address drug shortages across health systems, manufacturers and policymakers. Before Ascension, he held senior leadership roles at Premier, supporting more than 4,400 health systems, and spent 15 years at Cleveland Clinic building ambulatory pharmacy services.
Marva Williams-Lowe, PharmD. Chief Pharmacy Officer for MUSC Health (Charleston, S.C.). Dr. Williams-Lowe was appointed as chief pharmacy officer for MUSC Health in May of 2022, following 29 years at Lebanon, N.H.-based Dartmouth Health. She is responsible for overseeing all pharmacy services for the system. Along with the chief pharmacy officer role, she assumed the associate dean of clinical affairs title at the MUSC College of Pharmacy.
Bryan Yourich, PharmD. Chief Pharmacy Officer at Duke University Health System (Durham, N.C.). Dr. Yourich serves as the chief pharmacy officer for Duke University Health System. He and his team, which comprises leadership, pharmacists, residents, technicians, learners and support staff, work collaboratively to provide patients with outstanding pharmacy services for inpatients, outpatients and research participants. One of his main priorities is ensuring quality enhancement and excellence across the system’s hospital beds and pharmacy locations.
Kenny Yu, PharmD. Senior Vice President and Chief Pharmacy Officer at Mount Sinai Health System (New York City). Dr. Yu serves as senior vice president and chief pharmacy officer at Mount Sinai Health System, a role he took on in February 2026. He joins the system from New York City-based NYU Langone Health, where he spent 16 years in pharmacy leadership roles, including senior director of pharmacy services and director of the system’s 340B program. In those roles, Dr. Yu led enterprisewide pharmacy strategy, managed regulatory compliance, and helped expand pharmacy operations and licensing across ambulatory care sites. Earlier in his career, he held oncology and ambulatory pharmacy leadership positions at NYU Langone’s Laura and Isaac Perlmutter Cancer Center. He also brings experience in EHR and technology transitions, including Epic implementation projects for pharmacy workflows.
At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.
